Measles seroprevalence among healthcare workers in South Korea during the post-elimination period

References

• Moss WJ. Measles. Lancet. 2017;390:2490–502. doi:10.1016/S0140-6736(17)31463-0.
   PubMed Web of Science ®Google Scholar
• McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2013;62:1–34.
   PubMed Web of Science ®Google Scholar
• Choi S, Cho EH. Analysis of the occurrence of measles in Korea, 2019. Public Health Wkly Rep. 2020;13:2445–58.
   Google Scholar
• Maltezou HC, Dedoukou X, Vernardaki A, Katerelos P, Kostea E, Tsiodras S, Mentis A, Saroglou G, Theodoridou M, Georgakopoulou T. Measles in healthcare workers during the ongoing epidemic in Greece, 2017-2018. J Hosp Infect. 2018;100:e261–3. doi:10.1016/j.jhin.2018.06.007.
   PubMed Web of Science ®Google Scholar
• Coppeta L, Pietroiusti A, Morucci L, Neri A, Ferraro M, Magrini A. Workplace vaccination against measles in a teaching hospital of Rome. J Hosp Infect. 2019;101:364–65. doi:10.1016/j.jhin.2018.11.022.
   PubMed Web of Science ®Google Scholar
• Fiebelkorn AP, Redd SB, Kuhar DT. Measles in healthcare facilities in the United States during the postelimination era, 2001-2014. Clin Infect Dis. 2015;61:615–18. doi:10.1093/cid/civ387.
   PubMed Web of Science ®Google Scholar
• Botelho-Nevers E, Cassir N, Minodier P, Laporte R, Gautret P, Badiaga S, Thiberville DJ, Ninove L, Charrel R, Brouqui P. Measles among healthcare workers: a potential for nosocomial outbreaks. Euro Surveill. 2011;16:19764.
   PubMedGoogle Scholar
• Kang HJ, Han YW, Kim SJ, Kim YJ, Kim AR, Kim JA, Jung HD, Eom HE, Park O, Kim SS. An increasing, potentially measles-susceptible population over time after vaccination in Korea. Vaccine. 2017;35:4126–32. doi:10.1016/j.vaccine.2017.06.058.
   PubMed Web of Science ®Google Scholar
• Jung J, Kim SK, Kwak SH, Hong MJ, Kim SH. Seroprevalence of measles in healthcare workers in South Korea. Infect Chemother. 2019;51:58–61. doi:10.3947/ic.2019.51.1.58.
   PubMed Web of Science ®Google Scholar
• Chang HH, Kim SW, Kwon KT, Kim HI, Kim MJ, Ryu SY, Kim HA, Hur J, Kwon HH, Hong HL. Preliminary report of seroprevalence of anti-measles immunoglobulin G among healthcare workers of 6 teaching hospitals of Daegu, Korea in 2019. Infect Chemother. 2019;51:54–57. doi:10.3947/ic.2019.51.1.54.
   PubMed Web of Science ®Google Scholar
• Kwak YG, Song JE, Oh GB, Jeong IH, Cho CR, Kim N, Yoo HM, Yoo GM, Lee MJ, Kim BN. Comparison of the seroprevalence of measles antibodies among healthcare workers in two Korean hospitals in 2019. Infect Chemother. 2020;52:93–97. doi:10.3947/ic.2020.52.1.93.
   PubMed Web of Science ®Google Scholar
• Park SH, Lee MS, Kim SR, Kwak YG. A nationwide survey on the hospital vaccination policies in Korea. J Korean Med Sci. 2020;35:e76. doi:10.3346/jkms.2020.35.e76.
   PubMed Web of Science ®Google Scholar
• Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, Crowcroft NS. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017;17:e420–8. doi:10.1016/S1473-3099(17)30307-9.
   PubMed Web of Science ®Google Scholar
• Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197:950–56. doi:10.1086/528993.
   PubMed Web of Science ®Google Scholar
• Whittle HC, Aaby P, Samb B, Jensen H, Bennett J, Simondon F. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet. 1999;353:98–102. doi:10.1016/S0140-6736(98)02364-2.
   PubMed Web of Science ®Google Scholar
• Dai B, Chen ZH, Liu QC, Wu T, Guo CY, Wang XZ, Fang HH, Xiang YZ. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Organ. 1991;69:415–23.
   PubMed Web of Science ®Google Scholar
• Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357:1903–15. doi:10.1056/NEJMoa066092.
   PubMed Web of Science ®Google Scholar
• Kang JH. Review of measles in Korea: quarantine and elimination. Infect Chemother. 2020;52:113–22. doi:10.3947/ic.2020.52.1.113.
   PubMed Web of Science ®Google Scholar
• Kim CS, Park O, Kim MY, Kim MJ, Lee SG, Jung HK. A study on registration data analysis of national immunization registry information system. J Korean Inst Info Commun Eng. 2015;19:1151–56. doi:10.6109/jkiice.2015.19.5.1151.
   Google Scholar
• Naniche D, Garenne M, Rae C, Manchester M, Buchta R, Brodine SK, Oldstone MB. Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. J Infect Dis. 2004;190:1387–95. doi:10.1086/424571.
   PubMed Web of Science ®Google Scholar
• Kennedy RB, Ovsyannikova IG, Thomas A, Larrabee BR, Rubin S, Poland GA. Differential durability of immune responses to measles and mumps following MMR vaccination. Vaccine. 2019;37:1775–84. doi:10.1016/j.vaccine.2019.02.030.
   PubMed Web of Science ®Google Scholar
• Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, Kulkarni A, Audet S, Mercader S, McGrew M, et al. Measles virus neutralizing antibody response, cell-mediated immunity, and immunoglobulin G antibody avidity before and after receipt of a third dose of measles, mumps, and rubella vaccine in young adults. J Infect Dis. 2016;213:1115–23. doi:10.1093/infdis/jiv555.
   PubMed Web of Science ®Google Scholar
• Haralambieva IH, Ovsyannikova IG, O’Byrne M, Pankratz VS, Jacobson RM, Poland GA. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine. 2011;29:4485–91. doi:10.1016/j.vaccine.2011.04.037.
   PubMed Web of Science ®Google Scholar
• de Ory F, Minguito T, Balfagon P, Sanz JC. Comparison of chemiluminescent immunoassay and ELISA for measles IgG and IgM. APMIS. 2015;123:648–51. doi:10.1111/apm.12413.
   PubMed Web of Science ®Google Scholar
• Ratnam S, Gadag V, Wet R, Burris J, Oates E, Stead F, Bouilianne N. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J Clin Microbiol. 1995;33:811–15. doi:10.1128/JCM.33.4.811-815.1995.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The immunological basis for immunization series: module 7: measles. Update 2020. Geneva (Switzerland): World Health Organization; 2020.
   Google Scholar